|By Marketwired .||
|June 10, 2014 04:04 PM EDT||
SAN DIEGO, CA -- (Marketwired) -- 06/10/14 -- PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the second fiscal quarter ended April 30, 2014.
Fiscal Q3 Milestones
The Company reported that during the third fiscal quarter 2014, the new management team generated significant momentum in advancing its business strategy to commercialize its SDC-based technology as a food safety solution:
- Extended commercial market test launch of PURE® Hard Surface Disinfectant to over 650 stores with a national brand QSR (quick service restaurant);
- Positive customer field feedback on both SDC product performance and ease of use
- Phased U.S. national rollout under development for expected system-wide launch
- Rollout plans in development for wider plant adoption from five national food processors who placed commercial pilot orders;
- Expanding SDC usage with enhanced hygiene and operating protocols
- Reported outstanding initial test results for the application of SDC as a direct food contact processing aid for raw poultry;
- Test results achieved undetectable levels of salmonella in raw poultry
- Enhanced safety profile provides benefit to both plant environment and staff
- Estimated potential addressable U.S. market opportunity for this new application exceeds $1 billion for poultry, produce and meats
- Filing for required regulatory authorization from the FDA and USDA is expected later this month for poultry and Q3 2014 for produce and meats
- Expected approval for U.S. commercial use by end of calendar 2014 for poultry
- Test results achieved undetectable levels of salmonella in raw poultry
Summary of Results of Operations
Revenues for the third fiscal quarter of 2014 were $261,000, compared with revenues of $258,000 for the third fiscal quarter of 2013. Total operating costs and expenses, excluding share-based compensation, other share-based expenses, and restructuring costs, for the third fiscal quarter of 2014 and 2013, were $1.7 million, and $1.7 million, respectively. The net loss for the third fiscal quarter of 2014 was $(2.1) million, or $(0.07) per share, compared with a net loss of $(1.5) million, or $(0.14) per share, in the third fiscal quarter of 2013.
Revenues for the nine months ended April 30, 2014 were $417,000, compared with revenues of $631,000 for the nine months ended April 30, 2013. Total operating costs and expenses, excluding share-based compensation, other share-based expense, and restructuring costs, were $4.4 million, and $5.2 million, respectively, a reduction of 15%. The net loss for the nine months ended April 30, 2014 was $(8.4) million, or $(0.34) per share, compared with a net loss of $(5.5) million, or $(0.53) per share, in the nine months ended April 30, 2013. The adjusted net loss for the nine months ended April 30, 2014, as adjusted for significant items, was $(3.8) million compared with prior year adjusted net loss of $(4.9) million, a decrease of approximately a $1.1 million, or 22%.
As the Company continues to execute its new business strategy, it intends to:
- Accelerate market penetration and revenue adoption of restaurant chains and food processors with SDC-based products
- Leverage out-sourcing of its manufacturing operations
- Out-license the SDC-technology platform to non-food markets
- Secure additional capital to execute its business plan
Calendar 2014 Goals
- Increase financial strength to accelerate strategy execution.
- Secure customer adoption in food safety with 2+ national QSR chains and 5+ national food processors;
a. Fiscal 4Q 2014 (July 31 2014): annual revenue run rate $3-$5M
b. Fiscal 4Q 2015 (July 31 2015): positive EBITDA
- Leverage outsourcing of operations and supply chain;
a. Provide incremental cost savings and increase production scale
- Secure FDA and USDA authorization for use of SDC as a direct food contact/processing aid;
a. Initiate commercialization as a processing aid for poultry by end of calendar 2014
- License PURE distribution and SDC applications to non-core markets.
Food Safety Solutions Provider
PURE's near-term business focus is to drive customer adoption of its products in the food industry. Its proprietary SDC-based products uniquely address food safety issues across the supply chain and help to prevent or mitigate food contamination and the potential for food-borne illness. The Company's target customers are foodservice operators, food processors and food manufacturers.
"This quarter operating results are in line with our expectations of completing the manufacturing technology transfer and initiating out-sourced production and distribution to our QSR market test and other customers," stated Peter C. Wulff, Chief Financial Officer and Chief Operating Officer. "We believe we are well positioned with our new operating structure to meet expected market demand."
Hank R. Lambert, Chief Executive Officer, said, "The recent progress we have made in extending the usage of PURE Hard Surface in QSRs and food processors, combined with compelling results generated by our testing of SDC as a processing aid for poultry, provide strong validation for our unique antimicrobial technology and give us great optimism for building revenue momentum in the coming months. We are increasingly confident that SDC will prove to be one of the most important advances in food safety in recent history."
Q3 Results Conference Call
The Company will host an investor conference call on Tuesday, June 10th, 2014 at 1:30pm PDT (4:30pm EDT).
The Participant Dial-In Number for the conference call is 1-412-902-6720. Participants should dial in to the call at least five minutes before 1:30pm PDT (4:30pm EDT) on June 10th, 2014. The call can also be accessed "live" or via replay online on the Company's website (http://www.purebio.com/about/investor_relations). The replay of the webcast will be available by dialing 1-877-870-5176 (international participants dial 1-858-384-5517) starting June 10th, 2014, at 7:30pm EDT through June 24th, 2014 at 11:59 pm EDT. Please use PIN Number 90610.
About PURE Bioscience, Inc.
PURE Bioscience, Inc. is focused on developing and commercializing its proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control within the food industry. The Company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection. As a platform technology, SDC is distinguished from existing products in the marketplace by its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company's cash position and liquidity requirements, the Company's failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, including to manufacture its products, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission, including our annual report on Form 10-K filed October 24, 2013. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
Pure Bioscience, Inc. Condensed Consolidated Statements of Operations (Unaudited) Nine months ended Three months ended April 30, April 30, ------------------------ ------------------------ 2014 2013 2014 2013 ----------- ----------- ----------- ----------- Net product sales $ 417,000 $ 631,000 $ 261,000 $ 258,000 Operating costs and expenses Cost of goods sold 145,000 155,000 89,000 67,000 Selling, general and administrative 3,506,000 4,093,000 1,338,000 1,332,000 Research and development 750,000 979,000 248,000 283,000 Share-based compensation 2,191,000 583,000 770,000 153,000 Other share-based expenses 308,000 - - - Restructuring costs 2,754,000 - - - ----------- ----------- ----------- ----------- Total operating costs and expenses 9,654,000 5,810,000 2,445,000 1,835,000 ----------- ----------- ----------- ----------- Loss from operations (9,237,000) (5,179,000) (2,184,000) (1,577,000) Other income (expense) Change in derivative liability (56,000) 270,000 3,000 30,000 Interest expense, net (7,000) (591,000) (2,000) (2,000) Gain on extinguishment of debt 727,000 - - - Other income (expense), net 198,000 (12,000) 134,000 15,000 ----------- ----------- ----------- ----------- Total other income (expense) 862,000 (333,000) 135,000 43,000 ----------- ----------- ----------- ----------- Net loss $(8,375,000) $(5,512,000) $(2,049,000) $(1,534,000) =========== =========== =========== =========== Basic and diluted net loss per share $ (0.34) $ (0.53) $ (0.07) $ (0.14) =========== =========== =========== =========== Shares used in computing basic and diluted net loss per share 24,479,959 10,310,721 27,864,746 11,255,833 =========== =========== =========== =========== Pure Bioscience, Inc. Condensed Consolidated Balance Sheets April 30, July 31, 2014 2013 ------------- ------------- (Unaudited) Assets Current assets Cash and cash equivalents $ 416,000 $ 32,000 Accounts receivable, net 34,000 18,000 Inventories, net 387,000 365,000 Prepaid expenses 194,000 71,000 ------------- ------------- Total current assets 1,031,000 486,000 Property, plant and equipment, net 42,000 146,000 Patents, net 1,378,000 1,430,000 ------------- ------------- Total assets $ 2,451,000 $ 2,062,000 ============= ============= Liabilities and stockholders' equity (deficit) Current liabilities Accounts payable $ 529,000 $ 1,134,000 Restructuring liability 512,000 - Note payable, current - 368,000 Accrued liabilities 105,000 600,000 Derivative liability 10,000 51,000 ------------- ------------- Total current liabilities 1,156,000 2,153,000 Note payable, less current portion - 887,000 Deferred rent - 13,000 ------------- ------------- Total liabilities 1,156,000 3,053,000 ------------- ------------- Commitments and contingencies Stockholders' equity (deficit) Preferred stock, $0.01 par value: 5,000,000 shares authorized, no shares issued - - Common stock, $0.01 par value: 100,000,000 shares authorized, 28,555,500 shares issued and outstanding at April 30, 2014, and 12,569,503 shares issued and outstanding at July 31, 2013 286,000 126,000 Additional paid-in capital 79,555,000 69,054,000 Accumulated deficit (78,546,000) (70,171,000) ------------- ------------- Total stockholders' equity (deficit) 1,295,000 (991,000) ------------- ------------- Total liabilities and stockholders' equity (deficit) $ 2,451,000 $ 2,062,000 ============= ============= Pure Bioscience, Inc. Reconciliation of Non-GAAP Financial Measures (Unaudited) Nine months ended Three months ended April 30, April 30, ------------------------ ------------------------ 2014 2013 2014 2013 ----------- ----------- ----------- ----------- Net loss, as reported $(8,375,000) $(5,512,000) $(2,049,000) $(1,534,000) Add back significant items: Share-based compensation 2,191,000 583,000 770,000 153,000 Other share-based expenses 308,000 - - - Restructuring costs 2,754,000 - - - Gain on extinguishment of debt (727,000) - - ----------- ----------- ----------- ----------- Net loss, as adjusted for significant items $(3,849,000) $(4,929,000) $(1,279,000) $(1,381,000) ----------- ----------- ----------- -----------
Most of us already know that adopting new cloud applications can boost a business’s productivity by enabling organizations to be more agile and ready to change course in our fast-moving and connected digital world. But the rapid adoption of cloud apps and services also brings with it profound security threats, including visibility and control challenges that aren’t present in traditional on-premises environments. At the same time, the cloud – because of its interconnected, flexible and adaptable...
Sep. 29, 2016 07:15 AM EDT Reads: 1,726
As organizations shift towards IT-as-a-service models, the need for managing and protecting data residing across physical, virtual, and now cloud environments grows with it. Commvault can ensure protection, access and E-Discovery of your data – whether in a private cloud, a Service Provider delivered public cloud, or a hybrid cloud environment – across the heterogeneous enterprise. In his general session at 18th Cloud Expo, Randy De Meno, Chief Technologist - Windows Products and Microsoft Part...
Sep. 29, 2016 07:00 AM EDT Reads: 2,933
DevOps at Cloud Expo, taking place Nov 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long dev...
Sep. 29, 2016 07:00 AM EDT Reads: 3,483
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform and how we integrate our thinking to solve complicated problems. In his session at 19th Cloud Expo, Craig Sproule, CEO of Metavine, will demonstrate how to move beyond today's coding paradigm ...
Sep. 29, 2016 07:00 AM EDT Reads: 3,409
Digitization is driving a fundamental change in society that is transforming the way businesses work with their customers, their supply chains and their people. Digital transformation leverages DevOps best practices, such as Agile Parallel Development, Continuous Delivery and Agile Operations to capitalize on opportunities and create competitive differentiation in the application economy. However, information security has been notably absent from the DevOps movement. Speed doesn’t have to negat...
Sep. 29, 2016 07:00 AM EDT Reads: 2,271
Fact is, enterprises have significant legacy voice infrastructure that’s costly to replace with pure IP solutions. How can we bring this analog infrastructure into our shiny new cloud applications? There are proven methods to bind both legacy voice applications and traditional PSTN audio into cloud-based applications and services at a carrier scale. Some of the most successful implementations leverage WebRTC, WebSockets, SIP and other open source technologies. In his session at @ThingsExpo, Da...
Sep. 29, 2016 06:45 AM EDT Reads: 1,671
Cognitive Computing is becoming the foundation for a new generation of solutions that have the potential to transform business. Unlike traditional approaches to building solutions, a cognitive computing approach allows the data to help determine the way applications are designed. This contrasts with conventional software development that begins with defining logic based on the current way a business operates. In her session at 18th Cloud Expo, Judith S. Hurwitz, President and CEO of Hurwitz & ...
Sep. 29, 2016 06:45 AM EDT Reads: 3,179
Leading cloud-centric IT organizations are establishing core capabilities to improve productivity, control costs and provide a highly responsive end-user experience. Key steps along this journey include creating an end-user cloud services catalog, automating workflows and provisioning, and implementing IT showback and chargeback. In his session at 19th Cloud Expo, Mark Jamensky, executive vice president of Products at Embotics, will walk attendees through an in-depth case study of enterprise I...
Sep. 29, 2016 06:15 AM EDT Reads: 1,471
SYS-CON Events announced today the Kubernetes and Google Container Engine Workshop, being held November 3, 2016, in conjunction with @DevOpsSummit at 19th Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA. This workshop led by Sebastian Scheele introduces participants to Kubernetes and Google Container Engine (GKE). Through a combination of instructor-led presentations, demonstrations, and hands-on labs, students learn the key concepts and practices for deploying and maintainin...
Sep. 29, 2016 06:00 AM EDT Reads: 2,760
Your business relies on your applications and your employees to stay in business. Whether you develop apps or manage business critical apps that help fuel your business, what happens when users experience sluggish performance? You and all technical teams across the organization – application, network, operations, among others, as well as, those outside the organization, like ISPs and third-party providers – are called in to solve the problem.
Sep. 29, 2016 06:00 AM EDT Reads: 2,679
SYS-CON Events announced today that Niagara Networks will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Niagara Networks offers the highest port-density systems, and the most complete Next-Generation Network Visibility systems including Network Packet Brokers, Bypass Switches, and Network TAPs.
Sep. 29, 2016 06:00 AM EDT Reads: 524
Without a clear strategy for cost control and an architecture designed with cloud services in mind, costs and operational performance can quickly get out of control. To avoid multiple architectural redesigns requires extensive thought and planning. Boundary (now part of BMC) launched a new public-facing multi-tenant high resolution monitoring service on Amazon AWS two years ago, facing challenges and learning best practices in the early days of the new service. In his session at 19th Cloud Exp...
Sep. 29, 2016 05:45 AM EDT Reads: 1,052
SYS-CON Events announced today that Roundee / LinearHub will exhibit at the WebRTC Summit at @ThingsExpo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. LinearHub provides Roundee Service, a smart platform for enterprise video conferencing with enhanced features such as automatic recording and transcription service. Slack users can integrate Roundee to their team via Slack’s App Directory, and '/roundee' command lets your video conference ...
Sep. 29, 2016 05:45 AM EDT Reads: 1,502
Using new techniques of information modeling, indexing, and processing, new cloud-based systems can support cloud-based workloads previously not possible for high-throughput insurance, banking, and case-based applications. In his session at 18th Cloud Expo, John Newton, CTO, Founder and Chairman of Alfresco, described how to scale cloud-based content management repositories to store, manage, and retrieve billions of documents and related information with fast and linear scalability. He addres...
Sep. 29, 2016 05:30 AM EDT Reads: 2,961
Apache Hadoop is a key technology for gaining business insights from your Big Data, but the penetration into enterprises is shockingly low. In fact, Apache Hadoop and Big Data proponents recognize that this technology has not yet achieved its game-changing business potential. In his session at 19th Cloud Expo, John Mertic, director of program management for ODPi at The Linux Foundation, will explain why this is, how we can work together as an open data community to increase adoption, and the i...
Sep. 29, 2016 05:30 AM EDT Reads: 1,148